Virus vs. superbug: new weapon tested for deadly heart infections
NCT ID NCT06870409
Summary
This study is testing if adding a special virus-based treatment, called phage therapy, to standard antibiotics can improve outcomes for people with a serious heart infection called infective endocarditis. The trial will enroll 30 patients who are hospitalized with this condition. The goal is to see if the combination therapy reduces hospital stays, dangerous complications, and death compared to antibiotics alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCARDITIS, BACTERIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Clinical Hospital named after V.V.Vinogradov (branch) of the Peoples' Friendship University of Russia named after Patrice Lumumba
RECRUITINGMoscow, Russia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.